Rasna Therapeutics (Dactinomycin Intellectual Property Rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Rasna Therapeutics (Dactinomycin Intellectual Property Rights) General Information

Description

A portfolio of intellectual property related to Actinomycin D.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 420 Lexington Avenue
  • Suite 2525
  • New York, NY 10170
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rasna Therapeutics (Dactinomycin Intellectual Property Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rasna Therapeutics (Dactinomycin Intellectual Property Rights)‘s full profile, request access.

Request a free trial

Rasna Therapeutics (Dactinomycin Intellectual Property Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Rasna Therapeutics (Dactinomycin Intellectual Property Rights)‘s full profile, request access.

Request a free trial